Department of Anaesthetics and Pain Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom; National Institute of Health Research Academic Clinical Fellow, King's College London, London, United Kingdom.
Department of Anaesthetics and Pain Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom; School of Cardiovascular Medicine and Metabolic Medicine and Sciences, King's College London, British Heart Foundation Centre of Excellence, Faculty of Life Sciences and Medicine, London, United Kingdom.
J Cardiothorac Vasc Anesth. 2022 Dec;36(12):4460-4482. doi: 10.1053/j.jvca.2022.08.016. Epub 2022 Aug 28.
Acute kidney injury (AKI) is one of the most common major complications of cardiac surgery, and is associated with increased morbidity and mortality. Cardiac surgery-associated AKI has a complex, multifactorial etiology, including numerous factors such as primary cardiac dysfunction, hemodynamic derangements of cardiac surgery and cardiopulmonary bypass, and the possibility of a large volume of blood transfusion. There are no truly effective pharmacologic therapies for the management of AKI, and, therefore, anesthesiologists, intensivists, and cardiac surgeons must remain vigilant and attempt to minimize the risk of developing renal dysfunction. This narrative review describes the current state of the scientific literature concerning the specific aspects of cardiac surgery-associated AKI, and presents it in a chronological fashion to aid the perioperative clinician in their approach to this high-risk patient group. The evidence was considered for risk prediction models, preoperative optimization, and the intraoperative and postoperative management of cardiac surgery patients to improve renal outcomes.
急性肾损伤(AKI)是心脏手术最常见的主要并发症之一,与发病率和死亡率增加有关。心脏手术相关 AKI 的病因复杂,多因素,包括原发性心功能障碍、心脏手术和体外循环的血流动力学紊乱,以及大量输血的可能性等。目前,对于 AKI 的管理还没有真正有效的药物治疗方法,因此,麻醉师、重症监护医师和心脏外科医师必须保持警惕,并尽量降低发生肾功能障碍的风险。本综述描述了与心脏手术相关 AKI 相关的特定方面的当前科学文献状态,并以时间顺序呈现,以帮助围手术期临床医生对这一高危患者群体进行治疗。对风险预测模型、术前优化以及心脏手术患者的术中及术后管理进行了证据评估,以改善肾脏预后。